STUDY OBJECTIVES: Inspiratory flow limitation (IFL) during sleep occurs when airflow remains constant despite an increase in respiratory effort. This respiratory event has been recognized as an important parameter for identifying sleep breathing disorders. The purpose of this study was to investigate how much IFL normal individuals can present during sleep. DESIGN: Cross-sectional study derived from a general population sample. SETTING: A "normal" asymptomatic sample derived from the epidemiological cohort of São Paulo. PATIENTS AND PARTICIPANTS: This study was derived from a general population study involving questionnaires and nocturnal polysomnography of 1,042 individuals. A subgroup defined as a nonsymptomatic healthy group was used as the normal group. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: All participants answered several questionnaires and underwent full nocturnal polysomnography. IFL was manually scored, and the percentage of IFL of total sleep time was considered for final analysis. The distribution of the percentage of IFL was analyzed, and associated factors (age, sex, and body mass index) were calculated. There were 95% of normal individuals who exhibited IFL during less than 30% of the total sleep time. Body mass index was positively associated with IFL. CONCLUSIONS: Inspiratory flow limitation can be observed in the polysomnography of normal individuals, with an influence of body weight on percentage of inspiratory flow limitation. However, only 5% of asymptomatic individuals will have more than 30% of total sleep time with inspiratory flow limitation. This suggests that only levels of inspiratory flow limitation > 30% be considered in the process of diagnosing obstructive sleep apnea in the absence of an apnea-hypopnea index > 5 and that < 30% of inspiratory flow limitation may be a normal finding in many patients.
STUDY OBJECTIVES: Inspiratory flow limitation (IFL) during sleep occurs when airflow remains constant despite an increase in respiratory effort. This respiratory event has been recognized as an important parameter for identifying sleep breathing disorders. The purpose of this study was to investigate how much IFL normal individuals can present during sleep. DESIGN: Cross-sectional study derived from a general population sample. SETTING: A "normal" asymptomatic sample derived from the epidemiological cohort of São Paulo. PATIENTS AND PARTICIPANTS: This study was derived from a general population study involving questionnaires and nocturnal polysomnography of 1,042 individuals. A subgroup defined as a nonsymptomatic healthy group was used as the normal group. INTERVENTIONS: N/A. MEASUREMENTS AND RESULTS: All participants answered several questionnaires and underwent full nocturnal polysomnography. IFL was manually scored, and the percentage of IFL of total sleep time was considered for final analysis. The distribution of the percentage of IFL was analyzed, and associated factors (age, sex, and body mass index) were calculated. There were 95% of normal individuals who exhibited IFL during less than 30% of the total sleep time. Body mass index was positively associated with IFL. CONCLUSIONS: Inspiratory flow limitation can be observed in the polysomnography of normal individuals, with an influence of body weight on percentage of inspiratory flow limitation. However, only 5% of asymptomatic individuals will have more than 30% of total sleep time with inspiratory flow limitation. This suggests that only levels of inspiratory flow limitation > 30% be considered in the process of diagnosing obstructive sleep apnea in the absence of an apnea-hypopnea index > 5 and that < 30% of inspiratory flow limitation may be a normal finding in many patients.
Authors: Christian Guilleminault; Ji Hyun Lee; Allison Chan; Maria-Cecilia Lopes; Yu-shu Huang; Agostinho da Rosa Journal: Sleep Med Date: 2005-07-01 Impact factor: 3.492
Authors: Robert B Fogel; John Trinder; David P White; Atul Malhotra; Jill Raneri; Karen Schory; Darci Kleverlaan; Robert J Pierce Journal: J Physiol Date: 2005-02-03 Impact factor: 5.182
Authors: R Condos; R G Norman; I Krishnasamy; N Peduzzi; R M Goldring; D M Rapoport Journal: Am J Respir Crit Care Med Date: 1994-08 Impact factor: 21.405
Authors: Christian Guilleminault; Kasey K Li; Andrei Khramtsov; Rafael Pelayo; Sandra Martinez Journal: Laryngoscope Date: 2004-01 Impact factor: 3.325
Authors: Sushmita Pamidi; Susan Redline; David Rapoport; Indu Ayappa; Luciana Palombini; Ramon Farre; Jason Kirkness; Jean-Louis Pépin; Olli Polo; Andrew Wellman; R John Kimoff Journal: Ann Am Thorac Soc Date: 2017-07
Authors: Adam Ogna; Nadia Tobback; Daniela Andries; Martin Preisig; Peter Vollenweider; Gerard Waeber; Pedro Marques-Vidal; José Haba-Rubio; Raphaël Heinzer Journal: J Clin Sleep Med Date: 2018-08-15 Impact factor: 4.062
Authors: Luciana B M de Godoy; Luciana O Palombini; Fernanda L Martinho Haddad; David M Rapoport; Tatiana de Aguiar Vidigal; Priscila Calixto Klichouvicz; Sergio Tufik; Sonia M Togeiro Journal: Lung Date: 2015-04-01 Impact factor: 2.584
Authors: Cynthia Y Callahan; Robert G Norman; Zachary Taxin; Anne M Mooney; David M Rapoport; Indu Ayappa Journal: Sleep Date: 2013-04-01 Impact factor: 5.849
Authors: Christian Guilleminault; Vivien C Abad; Hsiao-Yean Chiu; Brandon Peters; Stacey Quo Journal: Sleep Breath Date: 2015-09-02 Impact factor: 2.816